Phase II trial of NGR-hTNF and doxorubicin in relapsed small cell lung cancer (SCLC).
M. G. Vigano'
No relevant relationships to disclose
R. Cavina
No relevant relationships to disclose
S. Novello
No relevant relationships to disclose
F. Grossi
No relevant relationships to disclose
A. Santoro
No relevant relationships to disclose
V. Gregorc
No relevant relationships to disclose
G. Scagliotti
No relevant relationships to disclose
I. M. Garassino
No relevant relationships to disclose
G. Rossoni
No relevant relationships to disclose
M. G. Levra
No relevant relationships to disclose
C. Genova
No relevant relationships to disclose
F. Caligaris-Cappio
No relevant relationships to disclose
A. Lambiase
Employment or Leadership Position - MolMed S.p.A.
C. Bordignon
Employment or Leadership Position - MolMed S.p.A.